Horizon Therapeutics Public Lim Price Today
Horizon Therapeutics Public Lim
HZNP
Healthcare
$26.63B
💰
Market Cap
61.9
💸
Price to Earnings
$1.9
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Hold Consensus
Buy |
0 |
Strong Buy |
0 |
Hold |
8 |
Sell |
1 |
Strong Sell |
2 |
HZNP Price Forecast Target
116.3 👉 116.5 +0%
HZNP EPS Forecast
1.9 👉 5.7 +201%
Financials
Profit Margin
12 %
Revenue Growth
7.8 %
Dividend
$ 0
Held Percent
1.2% - Insiders
100.9% - Institutions
-2.1% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $2.2B
-
💰 Blackrock Inc. $1.5B
-
💰 Pentwater Capital Management Lp $1.3B
-
💰 Avoro Capital Advisors LLC $720.0M
-
💰 JP Morgan Chase & Company $564.8M
Stock Ideas
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…
Warren Buffet Portfolio
Invest like the oracle himself! View the stocks that Warren Buffett holds in the Berkshire Hathaway portfolio.
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …📮FAQ
Some Frequently Asked Questions.
The Horizon Therapeutics Public Lim industry is Drug Manufacturers—General
The Horizon Therapeutics Public Lim sector is Healthcare
The Horizon Therapeutics Public Lim forecasted predicted Price to Earnings PE ratio is 20.5
The Horizon Therapeutics Public Lim Price to Earnings PE ratio is 61.9
The Market Capitalization of Horizon Therapeutics Public Lim is $26.63B
There are total of 211059713 float shares with 100.9% held by Institutions and 1.2% held by insiders
The MHorizon Therapeutics Public Lim forecasted Earnings per Share EPS is $5.7
The Horizon Therapeutics Public Lim Earnings per Share EPS is 1.9
The Horizon Therapeutics Public Lim company has $2800556000 gross profits with 12 profit margins
The Horizon Therapeutics Public Lim Earnings Growth is 1.077% with 1.084% quarterly earnings growth
The Horizon Therapeutics Public Lim Revenue is $3644406016 with 0.078 revenue growth
The price target for Horizon Therapeutics Public Lim stock is $116.5 for the high target and $116.5 for the low target
The consensus analyst recommendations for Horizon Therapeutics Public Lim is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Horizon Therapeutics Public Lim is Hold, with the following breakdown:
- Buy: 0
- Strong Buy: 0
- Hold: 8
- Sell: 1
- Strong Sell: 2
The Beta of Horizon Therapeutics Public Lim is 1.0
The dividend of Horizon Therapeutics Public Lim is $0
The dividend yield of Horizon Therapeutics Public Lim is 0%
The biggest institutional and mutual fund holders of Horizon Therapeutics Public Lim stock are
- Vanguard Group Inc
- Blackrock Inc.
- Pentwater Capital Management Lp
- Avoro Capital Advisors LLC
The Horizon Therapeutics Public Lim ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0